Compare FBRT & BVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FBRT | BVS |
|---|---|---|
| Founded | 2012 | 2011 |
| Country | United States | United States |
| Employees | 223 | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 701.9M | 617.1M |
| IPO Year | N/A | 2016 |
| Metric | FBRT | BVS |
|---|---|---|
| Price | $9.06 | $10.60 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 3 |
| Target Price | $11.50 | ★ $14.00 |
| AVG Volume (30 Days) | ★ 587.9K | 455.4K |
| Earning Date | 04-29-2026 | 05-06-2026 |
| Dividend Yield | ★ 15.83% | N/A |
| EPS Growth | N/A | ★ 163.46 |
| EPS | N/A | ★ 0.04 |
| Revenue | N/A | ★ $568,087,000.00 |
| Revenue This Year | $12.34 | $7.52 |
| Revenue Next Year | $4.95 | $7.06 |
| P/E Ratio | ★ $13.56 | $268.00 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $8.24 | $5.81 |
| 52 Week High | $11.84 | $11.25 |
| Indicator | FBRT | BVS |
|---|---|---|
| Relative Strength Index (RSI) | 51.38 | 62.12 |
| Support Level | $8.91 | $8.27 |
| Resistance Level | $9.26 | $10.76 |
| Average True Range (ATR) | 0.19 | 0.54 |
| MACD | -0.00 | 0.04 |
| Stochastic Oscillator | 23.73 | 62.01 |
Franklin BSP Realty Trust Inc is a private real estate investment trust that originates, acquires, and manages a diversified portfolio of commercial real estate debt, and first mortgage loans. secured by properties located in the United States. The Company's operations are organized into two business units: (i) Commercial Real Estate Financing, and (ii) Agency Business. Its four reporting segments are as follows: The real estate debt business, The Agency Business, The commercial real estate conduit business, and The real estate owned business.
Bioventus Inc is a medical device company focused on developing and commercializing products to relieve pain and address musculoskeletal conditions. The company operates through two reporting segments, U.S. and International, and its product portfolio is organized into three main business areas: Pain Treatments, Surgical Solutions, and Restorative Therapies, offering products such as hyaluronic acid injections for osteoarthritis, peripheral nerve stimulation devices, bone graft substitutes, and ultrasound-based fracture healing therapies.